Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors

Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors

Abstract Background Immune checkpoint inhibition (ICI) improves survival outcomes for patients with several types of cancer including metastatic melanoma (MM), but serious immune-related adverse events requiring intervention with immunosuppressive medications occur in a subset of patients. Skin toxi...

Full description

Bibliographic Details
Main Authors: Nicholas Gulati, Douglas Donnelly, Yingzhi Qian, Una Moran, Paul Johannet, Judy Zhong, Iman Osman
Format: Article
Language:English
Published: BMC 2020-11-01
Series:Journal of Translational Medicine
Subjects:
Melanoma
Immune checkpoint inhibition
Immune-related adverse events
Skin toxicity
Advanced cancer
Online Access:http://link.springer.com/article/10.1186/s12967-020-02612-5

Internet

http://link.springer.com/article/10.1186/s12967-020-02612-5

Similar Items